Testosterone CIII
USP/1646009
Synonym: Testosterone; 17β-Hydroxy-3-oxo-4-androstene; 17β-Hydroxy-4-androsten-3-one; 4-Androsten-17β-ol-3-one; trans-Testosterone
CAS Number: 58-22-0
Empirical Formula (Hill Notation): C19H28O2
Molecular Weight: 288.42
EC Number: 200-370-5
MDL Number: MFCD00003654
Linear Formula: C19H28O2
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
drug control | USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada |
InChI | 1S/C19H28O2/c1-18-9-7-13( |
InChI key | MUMGGOZAMZWBJJ-DYKIIFRCSA |
manufacturer/tradename | USP |
SMILES string | C[C@]12CC[C@H]3[C@@H](CCC |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | Testosterone secreted by the testis is converted to dihydrotestosterone in the target tissues where it appears to mediate many of the biological actions of testosterone. Androgens direct the development of the male phenotype during embryogenesis and at puberty. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Other Notes: | USP issued SDS can be found here . |
Symbol | GHS07,GHS08,GHS09 |
Signal word | Danger |
Hazard statements | H302 - H351 - H360FD - H400 |
Precautionary statements | P201 - P280 - P301 + P312 + P330 - P308 + P313 |
Hazard Codes | T,N |
Risk Statements | 60-61-22-40-50 |
Safety Statements | 45-60-61 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |